Anebulo Pharmaceuticals (ANEB) News Today

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

$2.75

-0.25 (-8.33%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Anebulo Pharmaceuticals Inc 214 morningstar.com - April 17 at 10:31 PM
	Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Rises By 308.7% marketbeat.com - April 10 at 10:24 AM
	Analysts Are Bullish on These Healthcare Stocks: Acrivon Therapeutics, Inc. (ACRV), Abivax SA Sponsored ADR (ABVX) markets.businessinsider.com - April 2 at 9:20 PM
	Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Expands By 10.0% marketbeat.com - March 18 at 12:48 AM
	Milestone rallies 23% on FDA update for tachycardia drug msn.com - February 26 at 10:35 AM
	Anebulo Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Advances and Rapid FDA Track markets.businessinsider.com - February 16 at 1:09 PM
	New Debt & Financing Risk for Anebulo Pharmaceuticals, Inc. – What’s the Latest? msn.com - February 15 at 10:29 AM
	Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug msn.com - February 14 at 1:40 PM
	Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Large Decline in Short Interest marketbeat.com - February 14 at 6:54 AM
	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates finance.yahoo.com - February 13 at 5:35 PM
	Anebulo Pharmaceuticals (ANEB) to Release Quarterly Earnings on Thursday marketbeat.com - February 7 at 7:29 AM
	Anebulo Pharmaceuticals Stock (NASDAQ:ANEB) Dividends: History, Yield and Dates benzinga.com - January 20 at 11:32 AM
	Anebulo Pharmaceuticals, Inc. (ANEB) finance.yahoo.com - January 8 at 12:57 AM
	Anebulo Pharmaceuticals (FRA:214) Price Target Increased by 21.00% to 6.80 nasdaq.com - December 17 at 3:46 AM
	Anebulo Pharmaceuticals Inc ANEB morningstar.com - December 9 at 10:02 PM
	Analysts Have Conflicting Sentiments on These Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP) and Brainsway (BWAY) markets.businessinsider.com - November 21 at 11:55 PM
	Buy Recommendation for Anebulo Pharmaceuticals: Promising Financial Outlook and Potential Breakthrough in Acute Cannabis Intoxication Treatment markets.businessinsider.com - November 17 at 11:53 PM
	Anebulo Pharmaceuticals GAAP EPS of -$0.10 beats by $0.02 msn.com - November 15 at 1:14 PM
	Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates finance.yahoo.com - November 14 at 9:11 PM
	Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation finance.yahoo.com - November 6 at 12:06 PM
	Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year? msn.com - October 19 at 1:02 PM
	Director at Anebulo Pharmaceuticals Acquires Company Stock Options Worth 26,097 Shares benzinga.com - October 11 at 12:21 PM
	Anebulo Pharmaceuticals Names Richie Cunningham as CEO marketwatch.com - October 6 at 6:14 PM
	Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors finance.yahoo.com - October 6 at 6:14 PM
	Anebulo Pharmaceuticals Announces New CEO finance.yahoo.com - October 6 at 6:14 PM
	HC Wainwright & Co. Reiterates Anebulo Pharmaceuticals (ANEB) Buy Recommendation msn.com - September 25 at 7:42 PM
	H.C. Wainwright Sticks to Its Buy Rating for Anebulo Pharmaceuticals (ANEB) markets.businessinsider.com - September 25 at 9:41 AM
	Maxim Group Initiates Coverage of Anebulo Pharmaceuticals (ANEB) with Buy Recommendation nasdaq.com - September 23 at 3:24 PM
	Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Aurinia Pharmaceuticals (AUPH) and Aquestive Therapeutics (AQST) markets.businessinsider.com - September 22 at 7:49 AM
	Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates finance.yahoo.com - September 20 at 9:34 PM
	HC Wainwright & Co. Initiates Coverage of Anebulo Pharmaceuticals (ANEB) with Buy Recommendation msn.com - September 18 at 3:53 PM
	Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says markets.businessinsider.com - September 18 at 3:53 PM
	Anebulo Pharmaceuticals (ANEB) Has a New Rating from H.C. Wainwright markets.businessinsider.com - September 18 at 9:58 AM
	Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences finance.yahoo.com - August 30 at 6:31 PM
	Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001 finance.yahoo.com - August 22 at 2:28 PM
	Anebulo Pharma: FDA Provides Favorable Input On Studies To Support ANEB-001 Approval markets.businessinsider.com - August 21 at 3:14 PM
	Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension finance.yahoo.com - August 21 at 3:14 PM
	We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully finance.yahoo.com - May 30 at 10:07 AM
	Down -26.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Anebulo Pharmaceuticals, Inc. (ANEB) finance.yahoo.com - May 19 at 1:53 PM
	Benchmark Reiterates Anebulo Pharmaceuticals (ANEB) Speculative Buy Recommendation msn.com - May 18 at 3:31 PM
	Anebulo Pharmaceuticals, Inc.: Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates finanznachrichten.de - May 11 at 12:22 PM
	Anebulo Pharmaceuticals: Q3 Earnings Insights msn.com - May 11 at 12:22 PM
	Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates finance.yahoo.com - May 11 at 12:22 PM
	Antidote For THC? Anebulo Releases Positive Clinical Data Showing Potential Of Its Drug For Treatment Of Acute Cannabinoid Intoxication msn.com - March 29 at 3:52 PM
	Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication finance.yahoo.com - March 28 at 8:14 AM
	Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions finance.yahoo.com - March 8 at 4:59 PM
	Anebulo Pharmaceuticals Inc. barrons.com - February 19 at 1:27 PM
	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates finance.yahoo.com - February 10 at 10:45 AM
	Anebulo: Interesting Drug For Cannabis Intoxication, But The Market Potential Remains Unclear seekingalpha.com - January 27 at 8:13 PM
	Acute Cannabinoid Intoxication: This Pharma Company's Clinical Trials To Reduce And Treat Symptoms msn.com - January 9 at 4:51 PM

Get Anebulo Pharmaceuticals News Delivered to You Automatically

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

ANEB Media Mentions By Week

ANEB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANEB
News Sentiment
▼
0.00

0.53
▲
Average
Medical
News Sentiment

ANEB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANEB Articles
This Week
▼
1

0
▲
ANEB Articles
Average Week

Get Anebulo Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ANEB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Anebulo Pharmaceuticals (ANEB) News Today

ANEB Media Mentions By Week

ANEB Media Sentiment

ANEB News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info